A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-21
- Target Recruit Count
- 300
- Registration Number
- NCT00000918
- Locations
- 🇺🇸
UCLA CARE Ctr, Los Angeles, California, United States
🇺🇸Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸Cook County Hosp, Chicago, Illinois, United States
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
- Conditions
- Toxoplasmosis, CerebralHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-18
- Target Recruit Count
- 30
- Registration Number
- NCT00000674
- Locations
- 🇺🇸
USC CRS, Los Angeles, California, United States
🇺🇸Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸Univ. of Miami AIDS CRS, Miami, Florida, United States
A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-18
- Target Recruit Count
- 28
- Registration Number
- NCT00001020
- Locations
- 🇺🇸
St Louis Univ School of Medicine, St Louis, Missouri, United States
🇺🇸Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Children's Hospital & Medical Center / Seattle ACTU, Seattle, Washington, United States
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-05-21
- Target Recruit Count
- 444
- Registration Number
- NCT00000903
- Locations
- 🇺🇸
USC CRS, Los Angeles, California, United States
🇺🇸UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸Marin County Dept. of Health & Human Services, HIV/AIDS Program & Specialty Clinic, San Rafael, California, United States
The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
- Conditions
- HIV InfectionsHepatitis C
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-04-30
- Target Recruit Count
- 10
- Registration Number
- NCT00001035
- Locations
- 🇺🇸
NY Univ. HIV/AIDS CRS, New York, New York, United States
🇺🇸Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
🇺🇸USC CRS, Los Angeles, California, United States
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2012-04-17
- Target Recruit Count
- 120
- Registration Number
- NCT00001059
- Locations
- 🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸Queens Med. Ctr., Honolulu, Hawaii, United States
🇺🇸Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu, Hawaii, United States
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 37
- Registration Number
- NCT00000853
- Locations
- 🇺🇸
UAB AVEG, Birmingham, Alabama, United States
🇺🇸Univ. of Rochester AVEG, Rochester, New York, United States
🇺🇸UW - Seattle AVEG, Seattle, Washington, United States
The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 8
- Registration Number
- NCT00001105
- Locations
- 🇺🇸
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston, Massachusetts, United States
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 112
- Registration Number
- NCT00001042
- Locations
- 🇺🇸
St. Louis Univ. School of Medicine AVEG, Saint Louis, Missouri, United States
🇺🇸Univ. of Rochester AVEG, Rochester, New York, United States
🇺🇸UW - Seattle AVEG, Seattle, Washington, United States
Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-04
- Target Recruit Count
- 370
- Registration Number
- NCT00000816
- Locations
- 🇺🇸
Rush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States
🇺🇸Beth Israel Deaconess - East Campus A0102 CRS, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston, Massachusetts, United States